Cortexyme, Inc.
(NASDAQ : CRTX)

( )
CRTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -0.94%240.321.3%$790.96m
IMMUImmunomedics, Inc. 0.15%85.3011.0%$689.14m
MRNAModerna, Inc. -2.96%65.170.0%$688.38m
GILDGilead Sciences, Inc. -1.33%62.251.0%$574.97m
NVAXNovavax, Inc. 0.86%102.4496.5%$560.41m
ILMNIllumina, Inc. 4.88%286.313.5%$502.92m
REGNRegeneron Pharmaceuticals, Inc. -1.37%557.462.7%$425.08m
BIIBBiogen, Inc. -0.79%270.041.6%$333.15m
VRTXVertex Pharmaceuticals, Inc. -0.26%263.131.9%$328.25m
ALXNAlexion Pharmaceuticals, Inc. -0.37%112.022.0%$278.23m
SRNESorrento Therapeutics, Inc. -4.27%9.191.5%$246.35m
EXASEXACT Sciences Corp. 26.85%94.3120.7%$232.04m
SGENSeattle Genetics, Inc. 0.09%179.436.0%$203.87m
VXRTVaxart, Inc. -4.17%6.890.0%$198.58m
MNTAMomenta Pharmaceuticals, Inc. 0.19%52.393.0%$197.85m

Company Profile

Cortexyme, Inc. is a biopharmaceutical company, which develops therapeutics based on data supporting a new theory of the cause of Alzheimer's and other neurodegenerative disorders. Its product, COR388, is in clinical trial. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.